Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre S Asioli, A Righi, M Iommi, C Baldovini, F Ambrosi, F Guaraldi, M Zoli, ... European journal of endocrinology 180 (2), 127-134, 2019 | 100 | 2019 |
Hobnail variant of papillary thyroid carcinoma: a literature review F Ambrosi, A Righi, C Ricci, LA Erickson, RV Lloyd, S Asioli Endocrine pathology 28, 293-301, 2017 | 73 | 2017 |
Prognostic impact of MCPyV and TIL subtyping in Merkel cell carcinoma: Evidence from a large European cohort of 95 patients C Ricci, A Righi, F Ambrosi, D Gibertoni, F Maletta, S Uccella, F Sessa, ... Endocrine pathology 31, 21-32, 2020 | 37 | 2020 |
Outcome of endoscopic endonasal surgery in pediatric craniopharyngiomas D Mazzatenta, M Zoli, F Guaraldi, F Ambrosi, MF Fustini, E Pasquini, ... World Neurosurgery 134, e277-e288, 2020 | 36 | 2020 |
Histological evidence of diabetic kidney disease precede clinical diagnosis G Comai, D Malvi, A Angeletti, F Vasuri, S Valente, F Ambrosi, I Capelli, ... American journal of nephrology 50 (1), 29-36, 2019 | 31 | 2019 |
ST2L Transmembrane Receptor Expression: An Immunochemical Study on Endarterectomy Samples A Marzullo, F Ambrosi, M Inchingolo, F Manca, F Devito, D Angiletta, ... PLoS One 11 (5), e0156315, 2016 | 30 | 2016 |
Cutaneous melanomas: a single center experience on the usage of immunohistochemistry applied for the diagnosis C Ricci, E Dika, F Ambrosi, M Lambertini, G Veronesi, C Barbara International Journal of Molecular Sciences 23 (11), 5911, 2022 | 23 | 2022 |
PD-1 (PDCD1) promoter methylation in Merkel cell carcinoma: prognostic relevance and relationship with clinico-pathological parameters C Ricci, L Morandi, A Righi, D Gibertoni, F Maletta, F Ambrosi, ... Modern Pathology 32 (9), 1359-1372, 2019 | 22 | 2019 |
Does the site of origin of the microcarcinoma with respect to the thyroid surface matter? A multicenter pathologic and clinical study for risk stratification G Tallini, A De Leo, A Repaci, D de Biase, ML Bacchi Reggiani, ... Cancers 12 (1), 246, 2020 | 21 | 2020 |
Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients F Guaraldi, L Morandi, M Zoli, D Mazzatenta, A Righi, S Evangelisti, ... Clinical endocrinology 97 (6), 763-772, 2022 | 19 | 2022 |
Antitissue transglutaminase antibodies’ normalization after starting a gluten-free diet in a large population of celiac children-a real-life experience F Sbravati, A Cosentino, J Lenzi, M Fiorentino, F Ambrosi, A Salerno, ... Digestive and Liver Disease 54 (3), 336-342, 2022 | 16 | 2022 |
DNA methylation of steroidogenic enzymes in benign adrenocortical tumors: new insights in aldosterone-producing adenomas G Di Dalmazi, L Morandi, B Rubin, C Pilon, S Asioli, V Vicennati, ... The Journal of Clinical Endocrinology & Metabolism 105 (12), e4605-e4615, 2020 | 15 | 2020 |
Immunohistochemical expression of preferentially expressed antigen in melanoma (PRAME) in the uninvolved background testis, germ cell neoplasia in situ, and germ cell tumors of … C Ricci, T Franceschini, F Giunchi, M Grillini, F Ambrosi, F Massari, ... American Journal of Clinical Pathology 157 (5), 644-648, 2022 | 14 | 2022 |
PRAME expression in mucosal melanoma of the head and neck region C Ricci, MV Altavilla, B Corti, E Pasquini, L Presutti, AM Baietti, L Amorosa, ... The American Journal of Surgical Pathology 47 (5), 599-610, 2023 | 13 | 2023 |
Giant cell tumor of bone in patients under 16 years old: A single-institution case series F Ambrosi, A Righi, S Benini, G Magagnoli, I Chiaramonte, M Manfrini, ... Cancers 13 (11), 2585, 2021 | 13 | 2021 |
SOX2 and PRAME in the “reprogramming” of seminoma cells A Orsatti, M Sirolli, F Ambrosi, T Franceschini, F Giunchi, E Franchini, ... Pathology-Research and Practice 237, 154044, 2022 | 10 | 2022 |
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer M Mazzeschi, M Sgarzi, D Romaniello, V Gelfo, C Cavallo, F Ambrosi, ... Journal of Experimental & Clinical Cancer Research 41 (1), 113, 2022 | 9 | 2022 |
FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal‐type C Ricci, F Ambrosi, T Franceschini, F Giunchi, G Di Filippo, E Franchini, ... Histopathology 83 (3), 465-476, 2023 | 7 | 2023 |
Computerized tomography texture analysis of pheochromocytoma: relationship with hormonal and histopathological data A De Leo, G Vara, A Paccapelo, C Balacchi, V Vicennati, L Tucci, ... Journal of Endocrinological Investigation 45 (10), 1935-1944, 2022 | 6 | 2022 |
Intron 4–5 hTERT DNA hypermethylation in Merkel cell carcinoma: frequency, association with other clinico-pathological features and prognostic relevance C Ricci, L Morandi, F Ambrosi, A Righi, D Gibertoni, F Maletta, ... Endocrine Pathology 32 (3), 385-395, 2021 | 6 | 2021 |